Keyword Index

A

  • Adhesion Evaluation of Candida albicans biofilm formation on conventional and computer-aided-design/computer-aided manufacturing (CAD/CAM) denture base materials [Volume 8, Issue 3, 2022, Pages 23-29]
  • Airborne fungi Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021) [Volume 8, Issue 4, 2022, Pages 1-8]
  • ALT repeat Genotyping of Candida albicans Isolates Obtained from Vulvovaginal Candidiasis Patients from Zanjan, Iran, Based on ABC and RPS Typing Systems [Volume 8, Issue 4, 2022, Pages 9-14]
  • Angio-invasive Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Antifungal Resistance Candida auris and COVID-19: A health threatening combination [Volume 8, Issue 3, 2022, Pages 44-50]
  • Antifungals Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A singlecenter study in Iran [Volume 8, Issue 4, 2022, Pages 15-21]
  • Antifungal susceptibility Candidemia: Changing dynamics from a tertiary care hospital in North India [Volume 8, Issue 1, 2022, Pages 20-25]
  • Antifungal susceptibility Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran [Volume 8, Issue 3, 2022, Pages 9-17]
  • Antifungal susceptibility A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles [Volume 8, Issue 4, 2022, Pages 27-31]
  • Aspergillosis Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]
  • Aspergillosis A rare case of a nasal cavity fungus ball due to Aspergillus niger [Volume 8, Issue 3, 2022, Pages 39-43]
  • Aspergillus Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Aspergillus Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]
  • Aspergillus fumigatus Aspergillus fumigatus cerebral abscess following hemodialysis: A case report [Volume 8, Issue 4, 2022, Pages 32-36]
  • Aspergillus niger A rare case of a nasal cavity fungus ball due to Aspergillus niger [Volume 8, Issue 3, 2022, Pages 39-43]
  • Azole Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis [Volume 8, Issue 2, 2022, Pages 1-7]

B

  • Biofilm Evaluation of Candida albicans biofilm formation on conventional and computer-aided-design/computer-aided manufacturing (CAD/CAM) denture base materials [Volume 8, Issue 3, 2022, Pages 23-29]
  • BLOOD CULTURE Candidemia: Changing dynamics from a tertiary care hospital in North India [Volume 8, Issue 1, 2022, Pages 20-25]

C

  • C. albicans Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy [Volume 8, Issue 3, 2022, Pages 18-22]
  • Candida Candidemia: Changing dynamics from a tertiary care hospital in North India [Volume 8, Issue 1, 2022, Pages 20-25]
  • Candida Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy [Volume 8, Issue 3, 2022, Pages 18-22]
  • Candida Antifungal activity of essential oils against itraconazoleresistant pathogenic Candida isolated from vulvovaginal candidiasis [Volume 8, Issue 4, 2022, Pages 22-26]
  • Candida albicans complex Candida species isolated from clinical samples in a tertiary hospital in Honduras: Where is Candida auris? [Volume 8, Issue 3, 2022, Pages 1-8]
  • Candida auris Candida auris and COVID-19: A health threatening combination [Volume 8, Issue 3, 2022, Pages 44-50]
  • Candida colonization index High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in children’s medical center, Tehran, Iran [Volume 8, Issue 2, 2022, Pages 25-31]
  • Candida colonization index Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A singlecenter study in Iran [Volume 8, Issue 4, 2022, Pages 15-21]
  • Candida glabrata Epidemiology and molecular identification of mixed yeast isolates in Malaysia- A way forward [Volume 8, Issue 3, 2022, Pages 35-38]
  • Candida species Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis [Volume 8, Issue 2, 2022, Pages 1-7]
  • Candida species A comparative study on the production of extracellular hydrolytic enzymes of C. albicans and non-albicans Candida species isolated from HIV+/AIDS patients and healthy individuals [Volume 8, Issue 2, 2022, Pages 32-39]
  • Candida tropicalis Candidemia: Changing dynamics from a tertiary care hospital in North India [Volume 8, Issue 1, 2022, Pages 20-25]
  • Candidemia Risk factors and lethality associated with Candidemia in severe COVID-19 patients [Volume 8, Issue 1, 2022, Pages 32-38]
  • Candidemia Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran [Volume 8, Issue 3, 2022, Pages 9-17]
  • Candidemia Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran [Volume 8, Issue 3, 2022, Pages 30-34]
  • Candidiasis High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in children’s medical center, Tehran, Iran [Volume 8, Issue 2, 2022, Pages 25-31]
  • Candidiasis Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A singlecenter study in Iran [Volume 8, Issue 4, 2022, Pages 15-21]
  • Cerebral abscess Aspergillus fumigatus cerebral abscess following hemodialysis: A case report [Volume 8, Issue 4, 2022, Pages 32-36]
  • C. Glabrata Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy [Volume 8, Issue 3, 2022, Pages 18-22]
  • Chlorhexidine In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates [Volume 8, Issue 1, 2022, Pages 7-11]
  • Clinically suspected rhinosinusitis Time to speed up the diagnostic evaluation in clinically suspected rhinosinusitis patients: A debate on the conventional versus molecular workup to establish fungal infective etiology for prompt management [Volume 8, Issue 1, 2022, Pages 1-6]
  • Combination In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates [Volume 8, Issue 1, 2022, Pages 7-11]
  • COVID-19 Risk factors and lethality associated with Candidemia in severe COVID-19 patients [Volume 8, Issue 1, 2022, Pages 32-38]
  • COVID-19 First report of rhino-orbital mucormycosis caused by Syncephalastrum racemosum in a diabetic patient with COVID-19 in Iran and review of recent literature [Volume 8, Issue 2, 2022, Pages 49-54]
  • COVID-19 Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]
  • COVID-19 Candida auris and COVID-19: A health threatening combination [Volume 8, Issue 3, 2022, Pages 44-50]
  • Cryptococcus neoformans Cutaneous cryptococcal infection: Initial manifestation of acquired T-cell immunodeficiency due to malignant thymoma [Volume 8, Issue 2, 2022, Pages 55-58]
  • Cutaneous cryptococcosis Cutaneous cryptococcal infection: Initial manifestation of acquired T-cell immunodeficiency due to malignant thymoma [Volume 8, Issue 2, 2022, Pages 55-58]

D

  • Denture Evaluation of Candida albicans biofilm formation on conventional and computer-aided-design/computer-aided manufacturing (CAD/CAM) denture base materials [Volume 8, Issue 3, 2022, Pages 23-29]
  • Diabetes Pulmonary tuberculosis and rhinosinus mucormycosis coinfection in a diabetic patient [Volume 8, Issue 2, 2022, Pages 45-48]
  • Dianthus caryophyllus Efficacy of Syzygium aromaticum essential oil on the growth and enzymatic activity of pathogenic Candida albicans strains [Volume 8, Issue 1, 2022, Pages 12-19]

E

  • Echinocandin Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis [Volume 8, Issue 2, 2022, Pages 1-7]
  • Enzymatic activity Efficacy of Syzygium aromaticum essential oil on the growth and enzymatic activity of pathogenic Candida albicans strains [Volume 8, Issue 1, 2022, Pages 12-19]
  • Enzyme Activity A comparative study on the production of extracellular hydrolytic enzymes of C. albicans and non-albicans Candida species isolated from HIV+/AIDS patients and healthy individuals [Volume 8, Issue 2, 2022, Pages 32-39]
  • Epidemiology Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran [Volume 8, Issue 3, 2022, Pages 9-17]
  • Equipment Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021) [Volume 8, Issue 4, 2022, Pages 1-8]
  • Essential oil Antifungal activity of essential oils against itraconazoleresistant pathogenic Candida isolated from vulvovaginal candidiasis [Volume 8, Issue 4, 2022, Pages 22-26]

F

  • Fluconazole In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates [Volume 8, Issue 1, 2022, Pages 7-11]
  • Fluconazole Efficacy of Syzygium aromaticum essential oil on the growth and enzymatic activity of pathogenic Candida albicans strains [Volume 8, Issue 1, 2022, Pages 12-19]
  • Fungal rhinosinusitis Time to speed up the diagnostic evaluation in clinically suspected rhinosinusitis patients: A debate on the conventional versus molecular workup to establish fungal infective etiology for prompt management [Volume 8, Issue 1, 2022, Pages 1-6]
  • Fungus balls A rare case of a nasal cavity fungus ball due to Aspergillus niger [Volume 8, Issue 3, 2022, Pages 39-43]
  • Fusarium spp Disseminated fusariosis in children: Report of two cases in girls with leukemia [Volume 8, Issue 1, 2022, Pages 39-43]

G

  • Genotyping Genotyping of Candida albicans Isolates Obtained from Vulvovaginal Candidiasis Patients from Zanjan, Iran, Based on ABC and RPS Typing Systems [Volume 8, Issue 4, 2022, Pages 9-14]
  • Griseofulvin Synthesis and antifungal activity of novel griseofulvin nanoparticles with zinc oxide against dermatophytic fungi: Trichophyton mentagrophytes and Trichophyton verrucosum: A primary study [Volume 8, Issue 2, 2022, Pages 40-44]

H

  • Hematologic malignancy Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy [Volume 8, Issue 3, 2022, Pages 18-22]
  • Hospital Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021) [Volume 8, Issue 4, 2022, Pages 1-8]
  • HWP1 gene Candida species isolated from clinical samples in a tertiary hospital in Honduras: Where is Candida auris? [Volume 8, Issue 3, 2022, Pages 1-8]

I

  • ICU High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in children’s medical center, Tehran, Iran [Volume 8, Issue 2, 2022, Pages 25-31]
  • Identification Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran [Volume 8, Issue 3, 2022, Pages 30-34]
  • Indoor air Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021) [Volume 8, Issue 4, 2022, Pages 1-8]
  • Influenza Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]
  • Intensive Care Unit Risk factors and lethality associated with Candidemia in severe COVID-19 patients [Volume 8, Issue 1, 2022, Pages 32-38]
  • Intensive Care Unit Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran [Volume 8, Issue 3, 2022, Pages 30-34]
  • Invasive fungal infection Disseminated fusariosis in children: Report of two cases in girls with leukemia [Volume 8, Issue 1, 2022, Pages 39-43]

L

  • Laboratory diagnosis Time to speed up the diagnostic evaluation in clinically suspected rhinosinusitis patients: A debate on the conventional versus molecular workup to establish fungal infective etiology for prompt management [Volume 8, Issue 1, 2022, Pages 1-6]
  • Leukemia Disseminated fusariosis in children: Report of two cases in girls with leukemia [Volume 8, Issue 1, 2022, Pages 39-43]

M

  • Micafungin In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates [Volume 8, Issue 1, 2022, Pages 7-11]
  • Mixed yeast infections Epidemiology and molecular identification of mixed yeast isolates in Malaysia- A way forward [Volume 8, Issue 3, 2022, Pages 35-38]
  • Molecular detection Time to speed up the diagnostic evaluation in clinically suspected rhinosinusitis patients: A debate on the conventional versus molecular workup to establish fungal infective etiology for prompt management [Volume 8, Issue 1, 2022, Pages 1-6]
  • Molecular identification A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles [Volume 8, Issue 4, 2022, Pages 27-31]
  • Molecular methods Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Morphology characteristic A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles [Volume 8, Issue 4, 2022, Pages 27-31]
  • MspI Epidemiology and molecular identification of mixed yeast isolates in Malaysia- A way forward [Volume 8, Issue 3, 2022, Pages 35-38]
  • Mucor Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Mucorales Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates [Volume 8, Issue 1, 2022, Pages 26-31]
  • Mucormycosis Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Mucormycosis Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates [Volume 8, Issue 1, 2022, Pages 26-31]
  • Mucormycosis Pulmonary tuberculosis and rhinosinus mucormycosis coinfection in a diabetic patient [Volume 8, Issue 2, 2022, Pages 45-48]
  • Mucormycosis First report of rhino-orbital mucormycosis caused by Syncephalastrum racemosum in a diabetic patient with COVID-19 in Iran and review of recent literature [Volume 8, Issue 2, 2022, Pages 49-54]

N

  • Nanoparticles Synthesis and antifungal activity of novel griseofulvin nanoparticles with zinc oxide against dermatophytic fungi: Trichophyton mentagrophytes and Trichophyton verrucosum: A primary study [Volume 8, Issue 2, 2022, Pages 40-44]
  • Nasal cavity A rare case of a nasal cavity fungus ball due to Aspergillus niger [Volume 8, Issue 3, 2022, Pages 39-43]
  • Nasal tissue Time to speed up the diagnostic evaluation in clinically suspected rhinosinusitis patients: A debate on the conventional versus molecular workup to establish fungal infective etiology for prompt management [Volume 8, Issue 1, 2022, Pages 1-6]
  • Nystatin In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates [Volume 8, Issue 1, 2022, Pages 7-11]

O

  • Oral candidiasis A comparative study on the production of extracellular hydrolytic enzymes of C. albicans and non-albicans Candida species isolated from HIV+/AIDS patients and healthy individuals [Volume 8, Issue 2, 2022, Pages 32-39]
  • Outcomes Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]

P

  • Paddy field soil A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles [Volume 8, Issue 4, 2022, Pages 27-31]
  • PCR Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • PCR Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran [Volume 8, Issue 3, 2022, Pages 30-34]
  • PCR RFLP Epidemiology and molecular identification of mixed yeast isolates in Malaysia- A way forward [Volume 8, Issue 3, 2022, Pages 35-38]
  • Pediatric High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in children’s medical center, Tehran, Iran [Volume 8, Issue 2, 2022, Pages 25-31]
  • Pediatric Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A singlecenter study in Iran [Volume 8, Issue 4, 2022, Pages 15-21]
  • PICU High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in children’s medical center, Tehran, Iran [Volume 8, Issue 2, 2022, Pages 25-31]
  • Pneumonia Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [Volume 8, Issue 2, 2022, Pages 16-24]
  • Post-antifungal effect Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazolesusceptible and -resistant Candida albicans [Volume 8, Issue 2, 2022, Pages 8-15]

R

  • Radish Antifungal activity of essential oils against itraconazoleresistant pathogenic Candida isolated from vulvovaginal candidiasis [Volume 8, Issue 4, 2022, Pages 22-26]
  • Resistance Antifungal activity of essential oils against itraconazoleresistant pathogenic Candida isolated from vulvovaginal candidiasis [Volume 8, Issue 4, 2022, Pages 22-26]
  • Rhizopus Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Risk factor Risk factors and lethality associated with Candidemia in severe COVID-19 patients [Volume 8, Issue 1, 2022, Pages 32-38]
  • RPS Genotyping of Candida albicans Isolates Obtained from Vulvovaginal Candidiasis Patients from Zanjan, Iran, Based on ABC and RPS Typing Systems [Volume 8, Issue 4, 2022, Pages 9-14]

S

  • SARS-CoV-2 Candida auris and COVID-19: A health threatening combination [Volume 8, Issue 3, 2022, Pages 44-50]
  • Scedosporium dehoogii A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles [Volume 8, Issue 4, 2022, Pages 27-31]
  • Serum Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]
  • Sources of fungal contamination Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021) [Volume 8, Issue 4, 2022, Pages 1-8]
  • Syncephalastrum racemosum First report of rhino-orbital mucormycosis caused by Syncephalastrum racemosum in a diabetic patient with COVID-19 in Iran and review of recent literature [Volume 8, Issue 2, 2022, Pages 49-54]

T

  • Tinea corporis First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile [Volume 8, Issue 4, 2022, Pages 37-41]
  • T. quinckeanum First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile [Volume 8, Issue 4, 2022, Pages 37-41]

U

  • Urine Mucormycosis: A comparative update between conventional and molecular diagnosis strategies [Volume 8, Issue 1, 2022, Pages 44-53]

V

  • Vulvovaginal candidiasis Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis [Volume 8, Issue 2, 2022, Pages 1-7]

Y

  • Yeast Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran [Volume 8, Issue 3, 2022, Pages 30-34]

Z

  • ZnO Synthesis and antifungal activity of novel griseofulvin nanoparticles with zinc oxide against dermatophytic fungi: Trichophyton mentagrophytes and Trichophyton verrucosum: A primary study [Volume 8, Issue 2, 2022, Pages 40-44]